STK11 and Peutz-Jeghers syndrome: Some researchers claimed that IL-11-mediated activation of JAK/STAT3 was crucial in gastrointestinal carcinogenesis following LKB1 mutations and that targeting this pathway offers therapeutic potential in PJS (31).